AUPH
Price
$14.91
Change
-$1.00 (-6.29%)
Updated
Dec 3 closing price
Capitalization
1.97B
90 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$13.35
Change
+$0.83 (+6.63%)
Updated
Dec 3 closing price
Capitalization
945.81M
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUPH vs MLTX

Header iconAUPH vs MLTX Comparison
Open Charts AUPH vs MLTXBanner chart's image
Aurinia Pharmaceuticals
Price$14.91
Change-$1.00 (-6.29%)
Volume$3.04M
Capitalization1.97B
MoonLake Immunotherapeutics
Price$13.35
Change+$0.83 (+6.63%)
Volume$1.64M
Capitalization945.81M
AUPH vs MLTX Comparison Chart in %
AUPH
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUPH vs. MLTX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a Buy and MLTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (AUPH: $15.92 vs. MLTX: $12.54)
Brand notoriety: AUPH and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 39% vs. MLTX: 12%
Market capitalization -- AUPH: $1.97B vs. MLTX: $945.81M
AUPH [@Biotechnology] is valued at $1.97B. MLTX’s [@Biotechnology] market capitalization is $945.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, AUPH is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 3 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • AUPH’s TA Score: 3 bullish, 4 bearish.
  • MLTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than AUPH.

Price Growth

AUPH (@Biotechnology) experienced а -2.21% price change this week, while MLTX (@Biotechnology) price change was -7.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

AUPH is expected to report earnings on Mar 04, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.97B) has a higher market cap than MLTX($946M). AUPH YTD gains are higher at: 77.283 vs. MLTX (-76.842). AUPH has higher annual earnings (EBITDA): 86.5M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. AUPH (315M). MLTX has less debt than AUPH: MLTX (75.8M) vs AUPH (81.8M). AUPH has higher revenues than MLTX: AUPH (260M) vs MLTX (0).
AUPHMLTXAUPH / MLTX
Capitalization1.97B946M208%
EBITDA86.5M-196.98M-44%
Gain YTD77.283-76.842-101%
P/E Ratio26.63N/A-
Revenue260M0-
Total Cash315M425M74%
Total Debt81.8M75.8M108%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
50
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHMLTX
RSI
ODDS (%)
Bearish Trend 7 days ago
66%
Bullish Trend 7 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
57%
Momentum
ODDS (%)
N/A
Bullish Trend 7 days ago
73%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 15 days ago
82%
Bearish Trend 14 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
59%
Aroon
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMCIX25.54N/A
N/A
Calvert Small/Mid-Cap I
JMCRX22.11N/A
N/A
James Micro Cap
LOMGX36.60N/A
N/A
Lord Abbett Growth Opportunities F3
WLGAX39.30N/A
N/A
Nomura Large Cap Growth A
BCSFX24.61N/A
N/A
Brown Capital Mgmt Intl Sm Co Instl

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-1.55%
JSPR - AUPH
44%
Loosely correlated
-8.14%
FOLD - AUPH
41%
Loosely correlated
-0.71%
MLTX - AUPH
41%
Loosely correlated
-5.36%
VCYT - AUPH
39%
Loosely correlated
-0.43%
KALA - AUPH
38%
Loosely correlated
-16.54%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-5.36%
KALA - MLTX
87%
Closely correlated
-16.54%
IOBT - MLTX
75%
Closely correlated
-7.11%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-3.15%
NUVL - MLTX
48%
Loosely correlated
-1.37%
More